510 related articles for article (PubMed ID: 29320805)
1. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
Leemans J; Dooms C; Ninane V; Yserbyt J
Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment.
Habal P; Omran N; Jankovicova K; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):234-41. PubMed ID: 25059234
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
4. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
[TBL] [Abstract][Full Text] [Related]
5. [MODERN ASPECTS OF TREATMENT FOR EXUDATIVE PLEURITIS OF TUMORAL GENESIS].
Kolesnik AP; Kajoyan AV; Kuzmenko VA
Klin Khir; 2016; (11):71-3. PubMed ID: 30265791
[No Abstract] [Full Text] [Related]
6. Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set.
Mercer RM; Macready J; Jeffries H; Speck N; Kanellakis NI; Maskell NA; Pepperell J; Saba T; West A; Ali N; Corcoran JP; Hallifax RJ; Psallidas I; Asciak R; Hassan M; Miller RF; Rahman NM
Respirology; 2020 Jul; 25(7):750-755. PubMed ID: 31846131
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleurisy associated with primary lung cancer well controlled by pleurodesis using distilled water.
Sekiya M; Ishiwata T; Yoshimi K; Nagaoka T; Morio Y; Shiota S; Suzuki T; Seyama K; Takahashi K
Intern Med; 2009; 48(12):1051-5. PubMed ID: 19525597
[TBL] [Abstract][Full Text] [Related]
8. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
9. New biomarkers in the selection of patients for talcage of pleural cavity in the palliative therapy of malign pleural exudate.
Habal P; Omran N; Chek J; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):576-81. PubMed ID: 25690520
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
Verma A; Taha A; Venkateswaran S; Tee A
Singapore Med J; 2015 May; 56(5):268-73. PubMed ID: 26034319
[TBL] [Abstract][Full Text] [Related]
11. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
12. Thoracoscopic talc pleurodesis for malignant pleural effusion.
Love D; White D; Kiroff G
ANZ J Surg; 2003; 73(1-2):19-22. PubMed ID: 12534732
[TBL] [Abstract][Full Text] [Related]
13. [The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].
Hoksch B; Seidel N; Beshay M; Schmid RA
Zentralbl Chir; 2010 Feb; 135(1):54-8. PubMed ID: 20029741
[TBL] [Abstract][Full Text] [Related]
14. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM
Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984
[TBL] [Abstract][Full Text] [Related]
15. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
[TBL] [Abstract][Full Text] [Related]
16. Early and late mortality after pleurodesis for malignant pleural effusion.
Bernard A; de Dompsure RB; Hagry O; Favre JP
Ann Thorac Surg; 2002 Jul; 74(1):213-7. PubMed ID: 12118761
[TBL] [Abstract][Full Text] [Related]
17. [VATS in malignant pleural effusions].
Cui Y; Wang J; Liu T
Zhonghua Wai Ke Za Zhi; 1997 Nov; 35(11):675-6. PubMed ID: 10678010
[TBL] [Abstract][Full Text] [Related]
18. Tumor type influences the effectiveness of pleurodesis in malignant effusions.
Bielsa S; Hernández P; Rodriguez-Panadero F; Taberner T; Salud A; Porcel JM
Lung; 2011 Apr; 189(2):151-5. PubMed ID: 21331598
[TBL] [Abstract][Full Text] [Related]
19. Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.
Corcoran JP; Hallifax RJ; Mercer RM; Yousuf A; Asciak R; Hassan M; Piotrowska HE; Psallidas I; Rahman NM
Chest; 2018 Nov; 154(5):1115-1120. PubMed ID: 30243566
[TBL] [Abstract][Full Text] [Related]
20. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
